drugset / Trial / NCT01991145

Allogeneic UCB Therapy With EPO in Children With CP

NCT01991145

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This randomized controlled study aims to evaluate the efficacy and safety of allogeneic umbilical cord blood therapy combined with erythropoietin for children with cerebral palsy.

Timeline

Start
2013-11-26
Primary completion
2017-06-24
Completion
2017-06-24

Drugs

EvaluationDrugModalityDoseRoute
Subject epoetin alfa Protein / enzyme biologic 500 iu/kg

Indications